CXCL9 and neoplasm: CXCL9 could recruit not only CTL, inhibiting tumor development, but also other host immune cells, such as regulatory T cells (Tregs), tumor‐associated macrophages, and MDSC, which mediate immune tolerance in tumors 42, 43, 46, 47.